Home NDC 50242-007 Enspryng
Product NDC 50242-007
11-digit product format 502420007
Labeler code 50242
Product ID 50242-007_934d1456-ebad-46b5-8f09-ff9aed5e4e88
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Satralizumab
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Genentech, Inc.
Application BLA761149
Marketing category BLA
Marketing start 2020-08-14
Substance SATRALIZUMAB
Active strength 120 mg/mL
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Enspryng
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SATRALIZUMAB 120 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination YB18NF020M Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2391555 Internal RxNorm lookup 2391560 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-007-01 Enspryng 1 mL in 1 SYRINGE, PLASTIC INJECTION, SOLUTION 1 13 50242-007-01 Enspryng 1 in 1 CARTON INJECTION, SOLUTION 1 13 50242-007-86 Enspryng 1 in 1 CARTON INJECTION, SOLUTION 1 13 50242-007-86 Enspryng 1 mL in 1 SYRINGE, PLASTIC INJECTION, SOLUTION 1 13
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-007 ENSPRYNG (SATRALIZUMAB) INJECTION, SOLUTION [GENENTECH INC.] 10 Current NDC, Legacy NDC, 4 package rows 20250515_64c156a4-9bad-4d45-a294-0733c141f47b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761149 Enspryng satralizumab-mwge 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50242-007-01 50242000701 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 SYRINGE, PLASTIC 2020-08-14 0000-00-00 No No Current 50242-007-33 50242000733 1 SYRINGE in 1 CARTON (50242-007-33) / 1 mL in 1 SYRINGE 1 syringe 2026-06-10 1 Current 50242-007-55 50242000755 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-55) / 1 mL in 1 SYRINGE, PLASTIC 2026-06-10 0 Current 50242-007-86 50242000786 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86) / 1 mL in 1 SYRINGE, PLASTIC 2021-08-13 0000-00-00 Yes No Current